Back
Arch Capital Group Ltd. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Buy
59
ACGL
Arch Capital Group Ltd.
Last Price:
$95.85
Seasonality Move:
2.81%
Sell
45
ZBIO
Zenas BioPharma, Inc.
Last Price:
$35.81
Seasonality Move:
-8.13%
Buy
59
Arch Capital Group Ltd. (ACGL)
is a Buy
Is Arch Capital Group Ltd. a Buy, Sell or Hold?
-
The current Arch Capital Group Ltd. [ACGL] share price is $95.58. The Score for ACGL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
ACGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $36.89. The Score for ZBIO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACGL Stock Price Chart
What is Arch Capital Group Ltd.'s stock price today?
-
The Arch Capital Group Ltd. share price today is $95.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACGL is experiencing slight buying pressure.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $36.89The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.07 | Buy |
| Relative Strength Index (14 RSI): | 67 | Buy |
| Chaikin Money Flow: | 262010 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.39 - 93.95) | Buy |
| Bollinger Bands (100): | (87.81 - 92.81) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.97 | Buy |
| Relative Strength Index (14 RSI): | 51.69 | Buy |
| Chaikin Money Flow: | 321584 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ACGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.15 | Buy |
| 20-day SMA: | 92.87 | Buy |
| 50-day SMA: | 90.61 | Buy |
| 200-day SMA: | 91.06 | Buy |
| 8-day EMA: | 93.88 | Buy |
| 20-day EMA: | 92.76 | Buy |
| 50-day EMA: | 91.41 | Buy |
| 200-day EMA: | 91.5 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.29 | Sell |
| 20-day SMA: | 37.71 | Sell |
| 50-day SMA: | 32.54 | Buy |
| 200-day SMA: | 17.6 | Buy |
| 8-day EMA: | 37.45 | Sell |
| 20-day EMA: | 34.56 | Buy |
| 50-day EMA: | 23.69 | Buy |
| 200-day EMA: | 8.26 | Buy |
Arch Capital Group Ltd. Earnings Growth & ACGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.03 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
Arch Capital Group Ltd. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||